CICC Capital Promotes Dr. Zhang Xiao to Partner

Investment Circle (ID: pedaily2012) March 31 news,CEC CAPITALToday, it was announced thatPromotion of Dr. Zhang Xiao to Head of the Pharmaceuticals and Biotechnology Team, Healthcare Industry Group, at the CompanyPartner. He will become the firm's eighth partner.

Dr. Zhang Xiao joined CEC CAPITAL in 2016 and became the Head of the Pharmaceuticals and Biotechnology Team within the Healthcare Industry Group in 2018.Under his leadership, CEC Capital’s Pharmaceuticals and Biotechnology team has experienced rapid growth over the past three years,Successfully completed over 30 star projects, including Everest Medicines, Haihe Biopharma, CF PharmTech, Connect Biopharma, Arctic Vison, Thousand Oaks Biopharmaceuticals, 3D Medicines (Diagnostics), 3D Medicines (Pharmaceuticals), Boao Jingdian, Maie Translational Medicine, Xiantong Medicine, Yisheng Biopharma, Brii Biosciences, Shengsi Biologics, Kesarui Biologics, GenFang Pharma, Zesheng Technology, Dinghang Biologics, China Antibody, Sorrento Therapeutics, Caregen, Immune Onc, Vedanta Biosciences, and Stealth BioTherapeutics, with total financing exceeding USD 4 billion.2020,CEC Capital has set multiple industry transaction records in the pharmaceutical and biotechnology sectors, ranking first in the market for both the number of transactions and total transaction value in the primary market.

Dr. Zhang Xiao holds a bachelor’s degree from the University of Science and Technology of China and a Ph.D. in Chemistry and Biochemistry from Rutgers University in the United States. Prior to joining CEC CAPITAL, he served atCSC Financial Capital. After joining CEC CAPITAL, he was exceptionally promoted by two levels in 2019 and completed his journey from Senior Manager to Partner within five years.

Over the 21 years since its inception, CEC Capital has cultivated one asset that we cherish and take pride in above all else, beyond our brand: our increasingly mature partner culture. We welcome Zhang Xiao as our new partner and look forward to his leadership in guiding our growing pharmaceutical and biotechnology team to soar in a market with boundless growth potential. We also anticipate that more colleagues will join the partnership in the future, continuously injecting new momentum and vitality into our partner system.

——Founder & CEO of CEC CapitalWang RanMr.

“I am delighted to welcome another partner from the healthcare industry to CEC Capital, and I extend my sincere gratitude to Zhang Xiao and the pharmaceutical and biotechnology team he leads for their significant contributions to the firm. Zhang Xiao is the first individual in CEC Capital’s history to be promoted from Senior Manager to Partner. This achievement not only reflects his exceptional personal capabilities but also underscores CEC Capital’s merit-based talent philosophy and corporate culture. We firmly believe that, inspired by this culture and sense of mission, CEC Capital will continue to nurture more young talents and future leaders, which constitutes the fundamental foundation for our enduring success.”

——Partner and Co-Head of Healthcare Group, CEC CapitalLi GangMr.

More than four or five years ago, I carried passion andDreamPlusJoining CEC Capital, I aspired to make a mark in China’s new economy wave. At that time, the company was just establishing its biotechnology and innovative drug team, and the industry was in its early growth stage. Although the landscape was fraught with chaos and barrenness, this very environment provided young professionalsShi Zhanspace and the opportunity to carve out our own niche. The company has always fostered a culture of openness, trust, equality, and respect, extending ample trust and support to young professionals like us. This has allowed me sufficient time to refine and strengthen the team, leading everyone through continuous exploration, trial and error, iteration, and upgrades, gradually building it into the most outstanding and cohesive investment banking team in the industry. I am deeply grateful to the company for this, and I would like to express my special thanks to partners Li Gang and Irene for their steadfast support over the past few years.

——Dr. Zhang Xiao, Newly Promoted Partner at CEC Capital and Head of the Pharmaceuticals and Biotechnology Team within the Healthcare Industry Group